Cyaris was founded in 2026 based upon proprietary peptidic and non-peptidic macrocycle libraries, extensive screening data and clinical stage assets generated over more than 30 years of R & D and significant investment.  While many macrocycle companies utilize overwhelmingly peptidic, less chemically diverse and as yet clinically unvalidated macrocyclic compounds, Cyaris brings uniquely diverse, structurally intelligent and clinically validated datasets to leverage in drug discovery. 

The result is a platform positioned to:

• Increase the probability of hit discovery
• Accelerate time and lower costs to optimized leads
• Improve predictive power throughout the drug discovery and 
   development process

"Cyaris  - where intelligent macrocycle design and discipline fuel discovery."

Cyaris Inc.

Org chart

Teams

Offices

Cyaris Inc.

Org chart

Teams

Offices

Related companies